1 / 22

2010 Southeast Region Technology Transfer Director’s Meeting 7.30.2010 Scott Sewell

2010 Southeast Region Technology Transfer Director’s Meeting 7.30.2010 Scott Sewell Vice President Technology Acquisition & Development. Early Beginnings. Bloomington, Indiana. Overview. Cook established in 1963 – offers three products

carol
Download Presentation

2010 Southeast Region Technology Transfer Director’s Meeting 7.30.2010 Scott Sewell

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2010 Southeast Region Technology Transfer Director’s Meeting 7.30.2010 Scott Sewell Vice President Technology Acquisition & Development

  2. Early Beginnings

  3. Bloomington, Indiana

  4. Overview • Cook established in 1963 – offers three products • Today, 15,000+ products, 9,000+ employees worldwide, 16 medical entities, manufacturing on three continents, nine (9) strategic business units (SBUs), 2 shared service centers, distribution into more than 135 countries across more than 35 regulatory regions • Global representation interacting with 42 medical specialties focused on development of minimally-invasive and converging medical technologies (Devices, Biotechnology, Biopharma and Cell Therapy)

  5. Business Unit Focus • Aortic Intervention • Interventional technologies providing endovascular solutions for cardiovascular disease affecting aorta and its branch vessels - Vascular Surgery - Thoracic Surgery • Lead Management • A stand alone business emerging from Peripheral and Aortic Intervention • Electrophysiology - Cardiology • Critical Care • Antibiotic-Impregnated central venous catheters, difficult airway management devices. - Anesthesia - Critical Care Medicine - Emergency Medicine - Pulmonary Medicine - Pediatrics/Neonatology • Endoscopy • Interventional technologies that enhance efficient diagnoses and provide effective treatment for patients with biliary, pancreatic and esophageal/colonic/gastric diseases - Gastroenterology

  6. Business Unit Focus • • Peripheral Intervention • Vascular and non vascular access and treatment technologies supporting medical outcomes-based • interventional procedures in radiology, neuroradiology and vascular surgery • - Interventional Radiology • - Interventional Cardiology • - Vascular Surgery • • Surgery • Biodesigned regenerative scaffold technology used to signal the body to remodel weakened or • damaged soft tissue. • - General Surgery • - Colo-Rectal Surgery • - Plastic/Reconstructive Surgery • - Neurosurgery • Reconstructive Microsurgery • • Urology • Interventional and biodesigned technologies focusing on adult and pediatric urology with an emphasis • on stone management and pelvic health • Urology • • Women’s Health • Technologies to support reproduction, high risk obstetric and gynecologic procedures and incontinence • - Obstetrics • - Gynecology • - Embryology

  7. Core Technologies • BIOPHARMA-Cutting edge technology to enhance the development and delivery of vaccines and therapies. These are mammalian cell “factories” to produce the antibodies that deliever the targeted medicine. • Biotech – Biodesigned regenerative scaffold used to signal the body to remodel weakend or damaged soft tissue while providing long term strength and support. • Gene Therapy – Antisense, a gene –therapy compound that targets key genes responsible for cell migration and adhesion, collagen formation, secretion of extracellular matrix with potential use in drug eluting stents. • Cell Therapy – Extracting and deriving muscle-derived cells, this technology is used to treat various conditions where tissues have grown weak or lost their initial function.

  8. Unique Technologies

  9. Biotechnology Staple Line Reinforcement Dural Graft Anal Fistula Plug

  10. Aortic Aneurysm Repair

  11. Drug Eluting Stents

  12. Antibiotic Impregnated Catheters Spectrum Technology

  13. Winston-Salem, North Carolina

  14. In 1983, Don Wilson and Bill Cook saw the need for minimally invasive devices in the growing field of gastroenterology. Don Wilson Bill Cook

  15. Over 45 years of experience developing devices Our Process in a nutshell: • Gather ideas from a varietyof sources • Establish clinical developmentpartners (clinicians with interestand expertise in the selecteddevice area) • Develop a detailed understandingof the problem andproposed solution(s) • Evaluate prototypes • FDA Filing • Limited release/evaluation • Full release

  16. At the Forefront of Research and Development We have a successful history of commercializing devices and have the infrastructure and knowledge to support research projects such as NOTES to become a reality

  17. Cook is dedicated tobold leadershipin pioneeringinnovative medical solutionsto enhance patient careworldwide. – mission statement

More Related